Literature DB >> 30364932

Reply: TDP-43 mutations increase HNRNP A1-7B through gain of splicing function.

Martine Tétreault1,2, Jade-Emmanuelle Deshaies1,2, Sabrina Semmler2,3, Hadjara Sidibé1,2, Lulzim Shkreta4, Kathryn Volkening5,6, Hermona Soreq7,8, Michael J Strong5,6, Benoit Chabot4, Christine Vande Velde1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30364932      PMCID： PMC6262216          DOI： 10.1093/brain/awy261

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  18 in total

1.  Reversible behavioral phenotypes in a conditional mouse model of TDP-43 proteinopathies.

Authors:  Julio A Alfieri; Natalia S Pino; Lionel M Igaz
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

2.  TDP-43 mutations increase HNRNP A1-7B through gain of splicing function.

Authors:  Prasanth Sivakumar; Francesca De Giorgio; Agnieszka M Ule; Jacob Neeves; Remya R Nair; Matthew Bentham; Nicol Birsa; Jack Humphrey; Vincent Plagnol; Abraham Acevedo-Arozena; Thomas J Cunningham; Elizabeth M C Fisher; Pietro Fratta
Journal:  Brain       Date:  2018-12-01       Impact factor: 13.501

3.  An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex.

Authors:  Ye Zhang; Kenian Chen; Steven A Sloan; Mariko L Bennett; Anja R Scholze; Sean O'Keeffe; Hemali P Phatnani; Paolo Guarnieri; Christine Caneda; Nadine Ruderisch; Shuyun Deng; Shane A Liddelow; Chaolin Zhang; Richard Daneman; Tom Maniatis; Ben A Barres; Jian Qian Wu
Journal:  J Neurosci       Date:  2014-09-03       Impact factor: 6.167

4.  TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis.

Authors:  Jade-Emmanuelle Deshaies; Lulzim Shkreta; Alexander J Moszczynski; Hadjara Sidibé; Sabrina Semmler; Aurélien Fouillen; Estelle R Bennett; Uriya Bekenstein; Laurie Destroismaisons; Johanne Toutant; Quentin Delmotte; Kathryn Volkening; Stéphanie Stabile; Anaïs Aulas; Yousra Khalfallah; Hermona Soreq; Antonio Nanci; Michael J Strong; Benoit Chabot; Christine Vande Velde
Journal:  Brain       Date:  2018-05-01       Impact factor: 13.501

5.  Loss of TDP-43 causes age-dependent progressive motor neuron degeneration.

Authors:  Yohei Iguchi; Masahisa Katsuno; Jun-ichi Niwa; Shinnosuke Takagi; Shinsuke Ishigaki; Kensuke Ikenaka; Kaori Kawai; Hirohisa Watanabe; Koji Yamanaka; Ryosuke Takahashi; Hidemi Misawa; Shoichi Sasaki; Fumiaki Tanaka; Gen Sobue
Journal:  Brain       Date:  2013-02-28       Impact factor: 13.501

6.  Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation.

Authors:  Matthew J Winton; Lionel M Igaz; Margaret M Wong; Linda K Kwong; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Biol Chem       Date:  2008-02-27       Impact factor: 5.157

7.  Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice.

Authors:  Lionel M Igaz; Linda K Kwong; Edward B Lee; Alice Chen-Plotkin; Eric Swanson; Travis Unger; Joe Malunda; Yan Xu; Matthew J Winton; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Clin Invest       Date:  2011-01-04       Impact factor: 14.808

8.  Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43.

Authors:  Peter J Lukavsky; Dalia Daujotyte; James R Tollervey; Jernej Ule; Cristiana Stuani; Emanuele Buratti; Francisco E Baralle; Fred F Damberger; Frédéric H-T Allain
Journal:  Nat Struct Mol Biol       Date:  2013-11-17       Impact factor: 15.369

9.  A molecular mechanism realizing sequence-specific recognition of nucleic acids by TDP-43.

Authors:  Yoshiaki Furukawa; Yoh Suzuki; Mami Fukuoka; Kenichi Nagasawa; Kenta Nakagome; Hideaki Shimizu; Atsushi Mukaiyama; Shuji Akiyama
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

10.  Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis.

Authors:  Pietro Fratta; Prasanth Sivakumar; Jack Humphrey; Kitty Lo; Thomas Ricketts; Hugo Oliveira; Jose M Brito-Armas; Bernadett Kalmar; Agnieszka Ule; Yichao Yu; Nicol Birsa; Cristian Bodo; Toby Collins; Alexander E Conicella; Alan Mejia Maza; Alessandro Marrero-Gagliardi; Michelle Stewart; Joffrey Mianne; Silvia Corrochano; Warren Emmett; Gemma Codner; Michael Groves; Ryutaro Fukumura; Yoichi Gondo; Mark Lythgoe; Erwin Pauws; Emma Peskett; Philip Stanier; Lydia Teboul; Martina Hallegger; Andrea Calvo; Adriano Chiò; Adrian M Isaacs; Nicolas L Fawzi; Eric Wang; David E Housman; Francisco Baralle; Linda Greensmith; Emanuele Buratti; Vincent Plagnol; Elizabeth Mc Fisher; Abraham Acevedo-Arozena
Journal:  EMBO J       Date:  2018-05-15       Impact factor: 11.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.